Eaton Vance Worldwide Health Sci D
399 Boylston Street 12th Floor Boston MA 02116
Phone: 800-225-5478
| Category: | Intermediate-Term Bond | | Fund Family: | Natixis Funds | | Net Assets: | 17.66M | | Year-to-Date Return: | 26.44% | | Yield: | 4.07% | | Morningstar Rating: |  | | Fund Inception Date: | 12-Sep-03 |
|
Daniel J. Fuss
Lead Manager since
31-Dec-96 | | | Dan Fuss, CFA, CIC: began investment career in 1958; joined Loomis Sayles in 1976; has managed the Fund since inception; MBA, Marquette University. |
| Min Initial Investment: | $2,500 | | Min Initial Investment, IRA: | $1,000 | | Min Initial Investment, AIP: | $1,000 | | Min Subsequent Investment: | $100 | | Min Subsequent Investment, IRA: | $100 | | Min Subsequent Investment, AIP: | $50 |
|
| |
| The investment seeks high total investment return. The fund invests at least 80% of total assets in investment-grade fixed-income securities. It may invest up to 10% of total assets in lower rated securities. The fund may invest up to 20% of total assets in foreign securities, including emerging-markets securities. It may invest in fixed-income securities of any maturity and any portion of total assets in securities of Canadian issuers. The fund may not invest in equity securities of any kind. |
| Last Dividend
(1-Dec-09):
| 0.04 | | Last Cap Gain
(29-Dec-08):
| 0.13 | | Annual Holdings Turnover
| 30.00% | | Average for Category:
| 226.70% |
|
| Expense | LGBBX | Category
Avg | | Total Expense Ratio: | %
| 0.96% | | Max 12b1 Fee: | %
| N/A | | Max Front End Sales Load: | %
| 4.17% | | Max Deferred Sales Load: | 5.00%
| 2.65% | | 3 Yr Expense Projection*: |
$N/A | $460 | | 5 Yr Expense Projection*: |
$N/A | $712 | | 10 Yr Expense Projection*: |
$N/A | $1,435 |
|
|
